Below expectations: CSE Holdings' Q2 profit dipped by 6% in Q2

It was dragged down by higher tax rates.

CSE Global Limited reported a 6.0% YoY decline in its profits from continuing operations to S$8.0m in Q2, despite a 16.3% jump in revenue to S$108.1m.

Profits were dragged down by a higher-than-expected effective tax rate and fell short of analyst expectations.

According to OCBC, for 1H14, revenue grew 6.2% to S$201.3m, while PATMI from continuing operations fell 9.1% to S$15.6m.

“This constituted 50.0% and 43.2% of our FY14 forecasts, respectively. An interim DPS of 1.25 S cents was declared (payable on 27 Aug 2014), a slight decline from the 1.5 S cents declared in 2Q13. CSE also registered a 9.3% YoY decrease in its new orders received to S$95.4m, while outstanding orders were S$194.7m (-28.6% YoY), as at end 2Q14,” noted OCBC.
 

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare